Bioprocessing Market Outlook (2nd Ed.)


Looking for our most recent market research report on this topic? Click here.

Manufacturing biologics is a much more involved and complicated process than the chemical synthesis required for small molecule drugs. As a result, some sponsors are unlikely to outsource the process because of its complexity. Others are more likely to outsource bioprocessing because they need access to scientific expertise not possessed in-house.

ISR’s Bioprocessing Market Trends and Outsourcing Dynamics: 2018-2023 report affords readers the opportunity to gain insight into the bioprocessing market and where it’s heading. This report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what our survey respondents predict the marketplace will look like in five years. The report also explores the types of biologics sponsor organizations currently have in development and on the market and the likelihood of outsourcing a bioprocessing project by the type of biologic.

Bioprocessing Market Trends & Outsourcing Dynamics

Drug Developers:

  • Gain insight into where the biologics industry is heading over the next five years with respect to protein expression systems utilized and types of biologics in development.
  • Understand the CMO usage patterns of industry peers to identify whether additional outsourcing advantages can be obtained for your organization.
  • Learn the criteria used by peers to select bioprocessing contract manufacturers that help to scientifically and strategically evaluate service providers for bioprocessing projects.

Contract Manufacturers:

  • Pinpoint which CMO attributes have led to successful outsourcing relationships, those that have caused service providers to lose bids and what truly drives sponsor satisfaction, then internally assess your company on these metrics.
  • Identify changes in demand for outsourced activities and services in order to prepare for future needs.
  • Better position your company to win business by understanding the dynamics of different buyer groups (by sponsor company type and geography) and developing targeted marketing to speak directly to their unique needs.
  • Study Findings
  • Study Data
  • Demographics

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at

Bioprocessing Market Trends Bioprocessing Market Trends & Outsourcing Dynamics

Study Findings

Bioprocessing Market Dynamics

Motivations for Outsourcing Bioprocessing
Bioprocessing Project & CMO Volume
Bioprocessing Project & CMO Volume in 2023
Production Systems in Use
Types of Biologics Manufactured
Types of Biologics Manufactured by Company Size
Therapeutic Categories of Biologics
Dollar Value of Outsourced Bioprocessing Projects

Service Provider Perceptions and Selection

Department Influence on CMO Selection
Most Important Attributes for CMO Selection
Bioprocessing Contract Manufacturer Top 10 Areas for Excellence—Unprompted
Top Reasons for Service Provider Preference
Top Five Service Provider Satisfaction Drivers
Top 5 Reasons Service Providers Lose Bids
Number of Bioprocessing Preferred Providers

Trends, Predictions and Preferences

Biologics Market Growth Drivers—Unprompted
Geographic Preferences

Study Data

Bioprocessing Project Volume
Motivations for Outsourcing Bioprocessing
Outsourced Bioprocessing Current and 5 Years Out
In-house Bioprocessing by Geographic Location
Outsourced Bioprocessing by Geographic Location
Bioprocessing in China
Biologics in Development by Type
Biologics in Development by Therapeutic Area
Production Methods for Biologics in Development
Biologics Pipeline by Production Platform
In-house vs Outsourced Development Work
Likelihood of Outsourcing Biologics in Development by Type
Marketed Biologics by Type
Marketed Biologics by Therapeutic Area
Production Methods for Marketed Biologics
Marketed Products by Production Platform
In-house vs Outsourced Commercial Manufacturing
Likelihood of Outsourcing Marketed Biologics by Type
Marketed Biologics in 2023 by Type
Marketed Biologics in 2023 by Therapeutic Area
Production Methods Utilized in 2023
Biologics Portfolio in 2023 by Production Platform
In-house vs Outsourced Manufacturing in 2023
Bioprocessing Contract Manufacturer Areas for Excellence—Unprompted
Department Influence on CMO Selection
CMO Selection Attributes
Service Provider Satisfaction Drivers
Reasons Service Providers Lose Bids
Number of CMOs Used to Meet Bioprocessing Needs
Use of Preferred Providers
Number of Preferred Providers
Preferred Provider CMOs
Mentioned CMOs
Difficulty in Using a Non-Preferred Provider
Frequency of Modifying the Preferred Provider List
Service Provider Familiarity
Service Provider Consideration
Service Provider Use
Service Provider Preference
Top Reasons Expressed for Service Provider Preference—Unprompted
Verbatim Responses for Service Provider Preference
Annual Outsourced Bioprocessing Spend
Estimated Annual Outsourced Bioprocessing Spend in 2023
Outsourced Expenditure by Production Platform
Biologics Market Growth Drivers—Unprompted


Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement
Contract Manufacturer Involvement

Additional information


, ,